-
1
المؤلفون: Michael T. Nurmohamed, F. Turkstra, Willem F. Lems, Gertjan Wolbink, Ben A. C. Dijkmans, Carla A. Wijbrandts, R. M. van Vugt, G. M. Bartelds, L. A. Korswagen, D. van Schaardenburg, P. P. Tak, Charlotte L M Krieckaert
المساهمون: Clinical Immunology and Rheumatology, AII - Amsterdam institute for Infection and Immunity, Landsteiner Laboratory
المصدر: Arthritis and rheumatism, 63(4), 877-883. John Wiley and Sons Inc.
مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Immunology, Antibodies, Monoclonal, Humanized, Arthritis, Rheumatoid, Psoriatic arthritis, Rheumatology, Risk Factors, Internal medicine, Thromboembolism, medicine, Adalimumab, Immunology and Allergy, Humans, Pharmacology (medical), Prospective Studies, Prospective cohort study, Aged, Retrospective Studies, business.industry, Tumor Necrosis Factor-alpha, Incidence, Hazard ratio, Antibodies, Monoclonal, Retrospective cohort study, Middle Aged, medicine.disease, Surgery, Antibodies, Anti-Idiotypic, Treatment Outcome, Antirheumatic Agents, Cohort, Female, business, Cohort study, medicine.drug
-
2
المؤلفون: Lucien A. Aarden, M. Hart, Pauline A. van Schouwenburg, Gerrit Jan Wolbink, Diana Wouters, G. M. Bartelds
المساهمون: Landsteiner Laboratory
المصدر: Journal of immunological methods, 362(1-2), 82-88. Elsevier
مصطلحات موضوعية: Male, musculoskeletal diseases, Immunology, Anti-Inflammatory Agents, Arthritis, Antigen-Antibody Complex, Antibodies, Monoclonal, Humanized, Arthritis, Rheumatoid, Immunoglobulin Fab Fragments, immune system diseases, Immunopathology, medicine, Adalimumab, Immunology and Allergy, Animals, Humans, skin and connective tissue diseases, Autoimmune disease, Immunoassay, biology, business.industry, Immunogenicity, Antibodies, Monoclonal, nutritional and metabolic diseases, hemic and immune systems, medicine.disease, Antibodies, Anti-Idiotypic, Rheumatoid arthritis, Monoclonal, biology.protein, Female, Rabbits, Antibody, business, medicine.drug
-
3
المؤلفون: Willem F. Lems, Lucien A. Aarden, Paul P. Tak, Michael T. Nurmohamed, Ben A. C. Dijkmans, Gerrit Jan Wolbink, G. M. Bartelds, Carla A. Wijbrandts, S.O. Stapel
المساهمون: Clinical Immunology and Rheumatology, Landsteiner Laboratory, AII - Amsterdam institute for Infection and Immunity, Rheumatology, CCA - Innovative therapy, MOVE Research Institute, ICaR - Ischemia and repair, Faculteit der Geneeskunde
المصدر: Annals of the rheumatic diseases, 69(5), 817-821. BMJ Publishing Group
Annals of the Rheumatic Diseases, 69(5), 817-821. BMJ Publishing Group
Bartelds, G M, Wijbrandts, C A, Nurmohamed, M T, Stapel, S, Lems, W F, Aarden, L, Dijkmans, B A C, Tak, P P & Wolbink, G J 2010, ' Anti-infliximab and anti-adalimumab antibodies in relation to response to adalimumab in infliximab switchers and anti-tumour necrosis factor naive patients: a cohort study ', Annals of the Rheumatic Diseases, vol. 69, no. 5, pp. 817-821 . https://doi.org/10.1136/ard.2009.112847مصطلحات موضوعية: Adult, Male, musculoskeletal diseases, medicine.medical_specialty, Immunology, Arthritis, Antibodies, Monoclonal, Humanized, Severity of Illness Index, Gastroenterology, General Biochemistry, Genetics and Molecular Biology, Arthritis, Rheumatoid, Cohort Studies, Rheumatology, immune system diseases, Internal medicine, Adalimumab, Humans, Immunology and Allergy, Medicine, skin and connective tissue diseases, Aged, Tumor Necrosis Factor-alpha, business.industry, Antibodies, Monoclonal, Middle Aged, medicine.disease, Connective tissue disease, Infliximab, humanities, Treatment Outcome, Antirheumatic Agents, Immunoglobulin G, Rheumatoid arthritis, Monoclonal, Female, Tumor necrosis factor alpha, business, medicine.drug
وصف الملف: application/pdf
-
4
المؤلفون: Carla A. Wijbrandts, Jan L. Hoving, Michael T. Nurmohamed, Willem F. Lems, Alexandre E. Voskuyl, B A C Dijkmans, G. M. Bartelds, K. Sadiraj, Monique H. W. Frings-Dresen, I. Groot, PP Tak, Judith K. Sluiter
المساهمون: Rheumatology, CCA - Quality of life, ICaR - Ischemia and repair, Amsterdam Public Health, Coronel Institute of Occupational Health, Clinical Immunology and Rheumatology, Amsterdam institute for Infection and Immunity, Cancer Center Amsterdam
المصدر: Scandinavian Journal of Rheumatology, 38(4), 246-250. Informa Healthcare
Hoving, J L, Bartelds, G M, Sluiter, J K, Sadiraj, K, de Groot, I, Lems, W F, Dijkmans, B A C, Wijbrandts, C A, Tak, P P, Nurmohamed, M T, Voskuijl, A E & Frings-Dresen, M H W 2009, ' Perceived work ability, quality of life, and fatigue in patients with rheumatoid arthritis after a 6-month course of TNF inhibitors: prospective intervention study and partial economic evaluation ', Scandinavian Journal of Rheumatology, vol. 38, no. 4, pp. 246-250 . https://doi.org/10.1080/03009740902748264
Scandinavian journal of rheumatology, 38(4), 246-250. Informa Healthcareمصطلحات موضوعية: Adult, Male, Work, medicine.medical_specialty, Time Factors, Cost-Benefit Analysis, Injections, Subcutaneous, Immunology, Antibodies, Monoclonal, Humanized, Risk Assessment, Drug Administration Schedule, Arthritis, Rheumatoid, Disability Evaluation, Cost of Illness, Rheumatology, Quality of life, Internal medicine, medicine, Adalimumab, Humans, Immunology and Allergy, Outpatient clinic, Prospective Studies, Prospective cohort study, Fatigue, Netherlands, Dose-Response Relationship, Drug, Tumor Necrosis Factor-alpha, business.industry, Antibodies, Monoclonal, General Medicine, Middle Aged, medicine.disease, Checklist, Treatment Outcome, Antirheumatic Agents, Rheumatoid arthritis, Quality of Life, Physical therapy, Female, business, Risk assessment, Follow-Up Studies, medicine.drug
-
5
المؤلفون: J. B. A. Crusius, B A C Dijkmans, Michael T. Nurmohamed, R J van de Stadt, Paul P. Tak, I E van der Horst-Bruinsma, D. van Schaardenburg, G. M. Bartelds, Wouter H Bos, N. de Vries, Jennie Ursum, Gertjan Wolbink
المساهمون: Rheumatology, CCA - Disease profiling, Pathology, Amsterdam institute for Infection and Immunity, Clinical Immunology and Rheumatology, Landsteiner Laboratory
المصدر: Annals of the Rheumatic Diseases, 67(9), 1347-1350. BMJ Publishing Group
Bos, W H, Ursum, J, de Vries, N, Bartelds, G M, Wolbink, G J, Nurmohamed, M T, van der Horst-Bruinsma, I E, van de Stadt, R J, Crusius, J B A, Tak, P P, Dijkmans, B A C & van Schaardenburg, D 2008, ' The role of the shared epitope in arthralgia with anti-cyclic citrullinated peptide antibodies (anti-CCP), and its effect on anti-CCP levels ', Annals of the Rheumatic Diseases, vol. 67, no. 9, pp. 1347-1350 . https://doi.org/10.1136/ard.2008.089953
Annals of the rheumatic diseases, 67(9), 1347-1350. BMJ Publishing Groupمصطلحات موضوعية: musculoskeletal diseases, Adult, Male, medicine.medical_specialty, Immunology, Lower risk, Peptides, Cyclic, General Biochemistry, Genetics and Molecular Biology, Epitope, Serology, Arthritis, Rheumatoid, Epitopes, Rheumatology, immune system diseases, Risk Factors, Internal medicine, medicine, Immunology and Allergy, Humans, Allele, skin and connective tissue diseases, Aged, Autoantibodies, Aged, 80 and over, biology, business.industry, Arthritis, HLA-DR Antigens, Middle Aged, medicine.disease, Connective tissue disease, Arthralgia, Rheumatoid arthritis, biology.protein, Disease Progression, Female, Antibody, business, Biomarkers, HLA-DRB1 Chains
-
6
المؤلفون: Charlotte L M Krieckaert, Lucien A. Aarden, Willem F. Lems, G. M. Bartelds, Pauline A. van Schouwenburg, Michael T. Nurmohamed, Ben A. C. Dijkmans, Gerrit Jan Wolbink, Jos W. R. Twisk
المساهمون: Rheumatology, Epidemiology and Data Science, CCA - Innovative therapy, EMGO - Lifestyle, overweight and diabetes, ICaR - Ischemia and repair, Landsteiner Laboratory, Methodology and Applied Biostatistics, EMGO+ - Lifestyle, Overweight and Diabetes
المصدر: Bartelds, G M, Krieckaert, C L M, Nurmohamed, M T, van Schouwenburg, P A, Lems, W F, Twisk, J W, Dijkmans, B A C, Aarden, L & Wolbink, G J 2011, ' Development of antidrug antibodies against adalimumab and association with disease activity and treatment failure during long-term follow-up ', JAMA, vol. 305, no. 14, pp. 1460-1468 . https://doi.org/10.1001/jama.2011.406
JAMA, 305(14), 1460-1468. American Medical Associationمصطلحات موضوعية: Adult, Male, medicine.medical_specialty, medicine.drug_class, Context (language use), Monoclonal antibody, Antibodies, Monoclonal, Humanized, Gastroenterology, Arthritis, Rheumatoid, SDG 3 - Good Health and Well-being, Internal medicine, medicine, Adalimumab, Outpatient clinic, Humans, Prospective Studies, Treatment Failure, Prospective cohort study, Aged, business.industry, Remission Induction, Antibody titer, Antibodies, Monoclonal, General Medicine, Middle Aged, medicine.disease, Discontinuation, Rheumatoid arthritis, Antirheumatic Agents, Immunology, Antibody Formation, Female, business, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98e35249b282f058dca14ded60ab22a8
https://pubmed.ncbi.nlm.nih.gov/21486979 -
7
المؤلفون: Ben A. C. Dijkmans, G. M. Bartelds, Linda M. Peelen, Michael T. Nurmohamed, Wouter Ouwerkerk, Maarten Boers, Anita C.J. Ravelli, I.M. Visman
المساهمون: Other departments, Amsterdam Public Health, Amsterdam Reproduction & Development (AR&D), Medical Informatics, Rheumatology, Epidemiology and Data Science, CCA - Innovative therapy, ICaR - Ischemia and repair
المصدر: Journal of rheumatology, 38(9), 1884-1890. Journal of Rheumatology
Journal of Rheumatology, 38(9), 1884-1890. Journal of Rheumatology
Visman, I M, Bartelds, G M, Ouwerkerk, W, Ravelli, A C J, Peelen, L M, Dijkmans, B A C, Boers, M & Nurmohamed, M T 2011, ' Effect of the Application of Trial Inclusion Criteria on the Efficacy of Adalimumab Therapy in a Rheumatoid Arthritis Cohort ', Journal of Rheumatology, vol. 38, no. 9, pp. 1884-1890 . https://doi.org/10.3899/jrheum.101283مصطلحات موضوعية: musculoskeletal diseases, medicine.medical_specialty, Immunology, Arthritis, Antibodies, Monoclonal, Humanized, Severity of Illness Index, Arthritis, Rheumatoid, Cohort Studies, Disability Evaluation, Rheumatology, Internal medicine, Severity of illness, medicine, Adalimumab, Immunology and Allergy, Humans, Prospective Studies, Prospective cohort study, skin and connective tissue diseases, Clinical Trials as Topic, business.industry, Patient Selection, medicine.disease, Clinical trial, Treatment Outcome, Rheumatoid arthritis, Antirheumatic Agents, Cohort, Physical therapy, business, medicine.drug, Cohort study, Follow-Up Studies
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::689f3c90f47c1cffdeda395a33fdf38a
https://pure.amc.nl/en/publications/effect-of-the-application-of-trial-inclusion-criteria-on-the-efficacy-of-adalimumab-therapy-in-a-rheumatoid-arthritis-cohort(f1823a89-3160-4ee9-a0e6-f3f51cab15cb).html -
8
المؤلفون: Michael T. Nurmohamed, Dirkjan van Schaardenburg, Lucien A. Aarden, G. M. Bartelds, Anna Jamnitski, Pauline A. van Schouwenburg, S.O. Stapel, Gerrit Jan Wolbink, Ben A. C. Dijkmans
المساهمون: Rheumatology, CCA - Innovative therapy, ICaR - Ischemia and repair
المصدر: Jamnitski, A, Bartelds, G M, Nurmohamed, M T, van Schouwenburg, P A, van Schaardenburg, D, Stapel, S O, Dijkmans, B A C, Aarden, L & Wolbink, G J 2011, ' The presence or absence of antibodies to infliximab or adalimumab determines the outcome of switching to etanercept ', Annals of the Rheumatic Diseases, vol. 70, no. 2, pp. 284-288 . https://doi.org/10.1136/ard.2010.135111
Annals of the Rheumatic Diseases, 70(2), 284-288. BMJ Publishing Groupمصطلحات موضوعية: Adult, Male, medicine.medical_specialty, medicine.medical_treatment, Immunology, Arthritis, Antibodies, Monoclonal, Humanized, Gastroenterology, General Biochemistry, Genetics and Molecular Biology, Receptors, Tumor Necrosis Factor, Etanercept, Arthritis, Rheumatoid, Rheumatology, Internal medicine, Adalimumab, Immunology and Allergy, Medicine, Humans, Treatment Failure, Aged, Autoantibodies, business.industry, Tumor Necrosis Factor-alpha, Antibodies, Monoclonal, Middle Aged, medicine.disease, Connective tissue disease, Infliximab, TNF inhibitor, Treatment Outcome, Rheumatoid arthritis, Antirheumatic Agents, Immunoglobulin G, Female, Drug Monitoring, business, Epidemiologic Methods, Biomarkers, medicine.drug
-
9
المساهمون: Rheumatology, CCA - Immuno-pathogenesis, MOVE Research Institute
المصدر: Arthritis Research & Therapy, 12(5). BioMed Central
Arthritis Research & Therapy
Krieckaert, C L, Bartelds, G M, Lems, W F & Wolbink, G J 2010, ' The effect of immunomodulators on the immunogenicity of TNF-blocking therapeutic monoclonal antibodies: a review ', Arthritis Research & Therapy, vol. 12, no. 5, pp. 217 . https://doi.org/10.1186/ar3147مصطلحات موضوعية: medicine.medical_specialty, medicine.drug_class, Arthritis, Azathioprine, Review, Monoclonal antibody, Internal medicine, Animals, Humans, Immunologic Factors, Medicine, Inflammation, biology, Tumor Necrosis Factor-alpha, business.industry, Immunogenicity, Antibodies, Monoclonal, medicine.disease, Rheumatology, Rheumatoid arthritis, Immunology, biology.protein, Drug Therapy, Combination, Methotrexate, Antibody, business, medicine.drug
وصف الملف: application/pdf
-
10
المؤلفون: Carla A. Wijbrandts, Ben A. C. Dijkmans, Peter H van Eede, M. Hart, Paul P. Tak, Lucien A. Aarden, Els R. de Groot, Gerrit Jan Wolbink, J. B. A. Crusius, Michael T. Nurmohamed, G. M. Bartelds
المساهمون: Rheumatology, CCA - Disease profiling, Pathology, ICaR - Ischemia and repair
المصدر: Arthritis Research & Therapy, 12(6). BioMed Central
Arthritis Research & Therapy
Bartelds, G M, Groot, E, Nurmohamed, M T, Hart, M H L, van Eede, P H, Wijbrandts, C A, Crusius, J B A, Dijkmans, B A C, Tak, P P, Aarden, L & Wolbink, G J 2010, ' Surprising negative association between IgG1 allotype disparity and anti-adalimumab formation: a cohort study ', Arthritis Research & Therapy, vol. 12, no. 6, pp. R221 . https://doi.org/10.1186/ar3208مصطلحات موضوعية: musculoskeletal diseases, Male, medicine.medical_specialty, medicine.drug_class, Immunology, Radioimmunoassay, Enzyme-Linked Immunosorbent Assay, Monoclonal antibody, Antibodies, Monoclonal, Humanized, Immunoglobulin G, Cohort Studies, Rheumatology, Immunoglobulin Gm Allotypes, Internal medicine, medicine, Adalimumab, Immunology and Allergy, Humans, skin and connective tissue diseases, biology, business.industry, Antibodies, Monoclonal, Middle Aged, Virology, Infliximab, Allotype, humanities, Antibodies, Anti-Idiotypic, Monoclonal, biology.protein, Female, Antibody, business, medicine.drug, Research Article
وصف الملف: application/pdf
PDF full text from Publisher 
Find this article in full text from Springer Verlag.